NO20032156D0 - Behandling av angstforstyrrelser - Google Patents
Behandling av angstforstyrrelserInfo
- Publication number
- NO20032156D0 NO20032156D0 NO20032156A NO20032156A NO20032156D0 NO 20032156 D0 NO20032156 D0 NO 20032156D0 NO 20032156 A NO20032156 A NO 20032156A NO 20032156 A NO20032156 A NO 20032156A NO 20032156 D0 NO20032156 D0 NO 20032156D0
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- anxiety disorders
- anxiety
- disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24901000P | 2000-11-15 | 2000-11-15 | |
US26536201P | 2001-01-31 | 2001-01-31 | |
PCT/US2001/027801 WO2002040006A2 (en) | 2000-11-15 | 2001-11-06 | Treatment of anxiety disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20032156L NO20032156L (no) | 2003-05-13 |
NO20032156D0 true NO20032156D0 (no) | 2003-05-13 |
Family
ID=26939750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20032156A NO20032156D0 (no) | 2000-11-15 | 2003-05-13 | Behandling av angstforstyrrelser |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1395253A2 (no) |
JP (1) | JP2004529073A (no) |
KR (1) | KR20030051812A (no) |
CN (1) | CN1822825A (no) |
AU (1) | AU2002217757A1 (no) |
BR (1) | BR0115301A (no) |
CA (1) | CA2426069A1 (no) |
CZ (1) | CZ20031339A3 (no) |
EA (1) | EA200300567A1 (no) |
HR (1) | HRP20030384A2 (no) |
IL (1) | IL155874A0 (no) |
MX (1) | MXPA03004190A (no) |
NO (1) | NO20032156D0 (no) |
PL (1) | PL366119A1 (no) |
SK (1) | SK5422003A3 (no) |
WO (1) | WO2002040006A2 (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002070457A1 (en) * | 2001-03-06 | 2002-09-12 | Eli Lilly And Company | Inhibitor of monoamine uptake |
CA2495452A1 (en) * | 2002-08-14 | 2004-02-26 | Pharmacia & Upjohn Company Llc | Use of reboxetine for the treatment of hot flashes |
GB0309440D0 (en) * | 2003-04-25 | 2003-06-04 | Lilly Co Eli | Quinolone derivatives |
WO2004103356A2 (en) * | 2003-05-15 | 2004-12-02 | Eli Lilly And Company | Treatment of emotional dysregulation |
WO2005060949A2 (en) * | 2003-12-12 | 2005-07-07 | Eli Lilly And Company | Selective norepinephrine reuptake inhibitors for the treatment of hot flashes, impulse control disorders and personality change due to a general medical condition |
US8440724B2 (en) | 2008-01-09 | 2013-05-14 | Mayo Foundation For Medical Education And Research | Inhibiting neurotransmitter reuptake |
WO2011056788A2 (en) * | 2009-11-03 | 2011-05-12 | Mayo Foundation For Medical Education And Research | Inhibiting neurotransmitter reuptake |
US20120220665A1 (en) * | 2009-11-03 | 2012-08-30 | Mayo Foundation For Medical Education And Research | Inhibiting Neurotransmitter Reuptake |
US9944618B2 (en) | 2013-03-14 | 2018-04-17 | Mayo Foundation For Medical Education And Research | Inhibiting neurotransmitter reuptake |
EA202192084A1 (ru) * | 2019-02-01 | 2021-10-20 | ХОФФМАН ТЕКНОЛОДЖИЗ ЭлЭлСи. | Композиции и способы для лечения связанных с тревожностью нарушений |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997041878A1 (en) * | 1996-05-07 | 1997-11-13 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
IT1305322B1 (it) * | 1998-04-23 | 2001-05-04 | Pharmacia & Upjohn Spa | Uso di reboxetina per il trattamento di disturbi nervosi |
DE60035232T2 (de) * | 1999-07-01 | 2008-02-14 | Pharmacia & Upjohn Co. Llc, Kalamazoo | (S,S)-Reboxetin zur Behandlung von chronischem Müdigkeits-Syndrom |
-
2001
- 2001-11-06 BR BR0115301-3A patent/BR0115301A/pt not_active IP Right Cessation
- 2001-11-06 CN CNA01818927XA patent/CN1822825A/zh active Pending
- 2001-11-06 CZ CZ20031339A patent/CZ20031339A3/cs unknown
- 2001-11-06 WO PCT/US2001/027801 patent/WO2002040006A2/en not_active Application Discontinuation
- 2001-11-06 MX MXPA03004190A patent/MXPA03004190A/es unknown
- 2001-11-06 SK SK542-2003A patent/SK5422003A3/sk not_active Application Discontinuation
- 2001-11-06 PL PL01366119A patent/PL366119A1/xx not_active Application Discontinuation
- 2001-11-06 AU AU2002217757A patent/AU2002217757A1/en not_active Abandoned
- 2001-11-06 CA CA002426069A patent/CA2426069A1/en not_active Abandoned
- 2001-11-06 KR KR10-2003-7006523A patent/KR20030051812A/ko not_active Application Discontinuation
- 2001-11-06 IL IL15587401A patent/IL155874A0/xx unknown
- 2001-11-06 EA EA200300567A patent/EA200300567A1/ru unknown
- 2001-11-06 EP EP01996376A patent/EP1395253A2/en not_active Withdrawn
- 2001-11-06 JP JP2002542380A patent/JP2004529073A/ja active Pending
-
2003
- 2003-05-13 NO NO20032156A patent/NO20032156D0/no not_active Application Discontinuation
- 2003-05-14 HR HR20030384A patent/HRP20030384A2/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002217757A1 (en) | 2002-05-27 |
NO20032156L (no) | 2003-05-13 |
WO2002040006A2 (en) | 2002-05-23 |
MXPA03004190A (es) | 2003-09-22 |
BR0115301A (pt) | 2004-12-14 |
JP2004529073A (ja) | 2004-09-24 |
CA2426069A1 (en) | 2002-05-23 |
HRP20030384A2 (en) | 2003-08-31 |
KR20030051812A (ko) | 2003-06-25 |
EA200300567A1 (ru) | 2004-10-28 |
EP1395253A2 (en) | 2004-03-10 |
CN1822825A (zh) | 2006-08-23 |
WO2002040006A3 (en) | 2003-12-24 |
CZ20031339A3 (cs) | 2003-10-15 |
PL366119A1 (en) | 2005-01-24 |
SK5422003A3 (en) | 2003-12-02 |
IL155874A0 (en) | 2003-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20040097L (no) | Kombinasjoner for behandling av inflammatoriske forstyrrelser | |
NO20024273D0 (no) | Terapeutiske anvendelser av PPAR-mediatorer | |
NO20031442L (no) | Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer | |
GB0007193D0 (en) | Treatment of movrmrnt disorders | |
NO20026263L (no) | Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser | |
NO20024775D0 (no) | Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte | |
NO20041386L (no) | Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser | |
NO20024486L (no) | Forbedret behandling av neovaskularisering | |
NO20020062L (no) | Behandling av nevrotiske forstyrrelser | |
DE60236743D1 (de) | Zur behandlung androgenabhängiger krankheiten | |
NO20032156D0 (no) | Behandling av angstforstyrrelser | |
NO20023425L (no) | Fremgangsmåte for lindring av angst | |
ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
NO20026219L (no) | Forbindelser for behandling av svekket fundisk relaksasjon | |
NO20024776D0 (no) | Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte | |
NO20024777L (no) | Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte | |
NO20024236L (no) | Behandling av psoriasis | |
NO20023803D0 (no) | Anvendelse av mirtazapin for behandling av sövnforstyrrelser | |
NO20010390D0 (no) | Behandling av angstsykdommer | |
DK1309322T3 (da) | Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser | |
NO20030717D0 (no) | Forbindelser for behandling av avhengighetsforstyrrelser | |
EE200200670A (et) | S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks | |
NO20024331D0 (no) | Behandling av lidelser relatert til det serotonerge system | |
NO20030767L (no) | Behandling av forbrenninger | |
NO20002538D0 (no) | Deteksjon av pusteforstyrrelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |